ROLE OF NESFATIN-1 IN MAINTAINING CARBOHYDRATE HOMEOSTASIS IN HYPERTENSIVE PATIENTS
Abstract
The aim of this study is to analyze changes in the nesfatin-1 level in hypertensive patients depending on the carbohydrate profile parameters. 83 hypertensive patients aged 33 to 77 years were examined. Nesfatin-1 levels were determined by enzyme immunoassay method. Hypertensive patients have significantly higher levels of adipocytokine than healthy people. Results of data analyses may indicate a possible antihyperglycemic and insulinotropic effect of nesfatin-1 in hypertensive patients with normoglycemia or prediabetes. Confirmation of these processes requires a special study.
Downloads
References
Kovalenko V. M. Sertsevo-sudinni hvorobi: medichno-sotsialne znachennya ta strategiya rozvitku kardiologiyi v Ukrayini / V. M. Kovalenko, A. P. Dorogoy // Ukrayinskiy kardiologichniy zhurnal. – 2016. – Dod. 3. – S. 5–14.
Bratus V. V. Ozhirenie, insulinorezistetnost, metabolicheskiy sindrom: fundamentalnyie i klinicheskie aspektyi / V. V. Bratus, T. V. Talaeva, V. A.Shumakov; pod red. V. N. Kovalenko. – K.: Chetverta hvilya, 2009. – 413 s.
Oh-I S. Identification of nesfatin-1 as a satiety molecule in the hypothalamus / S. Oh-I, H. Shimizu // Nature. – 2006. – № 443. – P. 709–712.
Goebel-Stengel M. Central and peripheral expression and distribution of NUCB2/nesfatin-1 / M. Goebel-Stengel, L. Wang // Current Pharmaceutical Design. – 2013. – № 19. – P. 6935–6940.
Nakata M. Nesfatin-1 enhances glucose-induced insulin secretion by promoting Ca(2+) influx through L-type channels in mouse islet beta-cells / M. Nakata, K. Manaka, S. Yamamoto [et al.] // Endocrine Journal. – 2011. – № 58. – P. 305–313.
Li Z. Peripheral effects of nesfatin-1 on glucose homeostasis / Z. Li, L. Gao, H. Tang [et al.] // PLoS ONE. – 2013. – № 8(8). – e71513.
Shimizu H. Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-independent mechanism / H. Shimizu, S. Oh-I // Endocrinology. – 2009. – № 150. – P. 662–671.
Tanida M. Nesfatin-1 stimulates renal sympathetic nerve activity in rats / M. Tanida, M. Mori // Neuroreport. – 2011. – № 22. – P. 309–312.
Liu F. Decreased plasma nesfatin-1 level is related to the thyroid dysfunction in patients with type 2 diabetes mellitus / F. Liu, Q. Yang, N. Gao [et al.] // Journal of Diabetes Research. – 2014. – № 2014. – 128014.
Li J. B. Effects of aging on the plasma levels of nesfatin-1 and adiponectin / J. B. Li, M. Nishida, K. Kaimoto [et al.] // Biomedical Reports. – 2014. – № 2. – P. 15–156.
Demidenko G. V. DisfunktsIya endoteliyu yak faktor rozvitku insulinorezistentnosti u hvorih na gipertonichnu hvorobu / G. V. Demidenko // Meditsina sogodni i zavtra. – 2012. – № 3–4. – S. 75–81.
Lastra G. Type 2 diabetes mellitus and hypertension: An update / G. Lastra, S. Syed, L. R. Kurukulasuriya [et al.] // Endocrinology and metabolism clinics of North America. – 2014. – № 43(1). – S. 103–122.
Yosten G. L. Nesfatin-1 exerts cardiovascular actions in brain^ possible interaction with the central melanocortin system / G. L. Yosten, W. K. Samson // American journal of physiology. Regulatory, integrative and comparative physiology. – 2009. – № 297(2). – P. 330–336.
Yamawaki H. A novel adipocytokine? Nesfatin-1 modulates peripheral arterial contractility and blood pressure in rats / H. Yamawaki, M. Takahashi, M. Mukohda [et al.] // Biochemical and Biophysical Research Communications. – 2012. – № 418(4). – P. 676–681.
Ramanjaneya M. Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity / M. Ramanjaneya, J Chen, J. E. Brown [et al.] // Endocrinology. – 2010. – № 151. – 3169–3180.
Copyright (c) 2017 M. O. Vizir, O. M. Kovalyova
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Journal of V. N. Karazin Kharkiv National University, series Medicine has following copyright terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work, with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.